Therefore, since gastric cancer is characterized by the overexpression of ASS, we suggest that using RNA silencing technology to downregulate ASS expression and ADI-PEG20 to deprive a tumor of arginine may inhibit tumor cell growth. This evidence concerns the gene ASS1 and gastric cancer.